Discontinued — last reported Q3 '22
Routine clinical testing and other services — Net revenues
Quest Diagnostics Routine clinical testing and other services — Net revenues increased by 1.9% to $1.12B in Q3 2022 compared to the prior quarter. Year-over-year, this metric declined by 7.5%, from $1.21B to $1.12B. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates higher testing volumes or improved pricing power within the core diagnostic segment, while a decrease may signal competitive pressure or reduced demand for standard laboratory services.
Detailed definition
This metric captures the total net revenue generated from routine clinical testing and related diagnostic services after...
Peer comparison
Comparable to core diagnostic revenue streams reported by other major clinical laboratory and healthcare diagnostics providers.
dgx_segment_routine_clinical_testing_and_other_services_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|
| Value | $1.15B | $1.21B | $1.07B | $1.10B | $1.12B |
| QoQ Change | — | +5.2% | -11.9% | +3.0% | +1.9% |
| YoY Change | — | — | — | -4.5% | -7.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Quest Diagnostics's routine clinical testing and other services — net revenues?
- Quest Diagnostics (DGX) reported routine clinical testing and other services — net revenues of $1.12B in Q3 2022.
- How has Quest Diagnostics's routine clinical testing and other services — net revenues changed year-over-year?
- Quest Diagnostics's routine clinical testing and other services — net revenues decreased by 7.5% year-over-year, from $1.21B to $1.12B.
- What does routine clinical testing and other services — net revenues mean?
- The total dollar amount of revenue earned from routine clinical diagnostic testing services.